Arkema (Euronext: AKE) reports Q2 2024 sales up 3.8% YoY at €2.5 billion, with EBITDA rising 8.2% to €451 million. The outlook remains optimistic despite expected Q3 seasonal challenges. Strategic investments and strong operations point to continued growth.